The rich history of Dyadic represents a microcosm of how modern biotechnology is revolutionizing science, medicine, agriculture, and engineering to improve how we feed, fuel, and heal the world.
Going forward we intend to focus on on the pharmaceutical industry which we have long believed is one of the most attractive opportunities in which to apply the C1 technology. We believe that the C1 technology platform has the potential to be a safe and efficient expression system to help pharmaceutical and biotech companies speed up the development and lower the cost of manufacturing biologic vaccines and drugs to bring more affordable treatments to a greater number of patients, while helping to ease the burden biologic drugs are having on patients and the global healthcare systems, but most importantly saving lives.
Location: United States, Florida, Jupiter Island
Employees: 11-50
Phone: +1 561-743-8333
Founded date: 1979
Investors 1
| Date | Name | Website |
| - | Montrose C... | montroseca... |
Mentions in press and media 20
| Date | Title | Description | Source |
| 08.08.2023 | Dyadic’s Revolutionary Animal-Free Bovine Serum Albumin to S... | Biotechnology company Dyadic International, Inc. (NASDAQ: DYAI) announces that independent analysis ... | vegconomis... |
| 08.06.2023 | The Week in AgriFoodTech: Green Coffee Co brews up $25m, Cha... | Despite a general scarcity of agrifoodtech funding this week, a few companies announced notable roun... | agfunderne... |
| 08.03.2022 | IWD 2022: Celebrating the Queens Of Alt Protein Who Are Forg... | 166 1 167 Shares 16 Mins Read The two biggest plant-based protein startups in the world are run by m... | greenqueen... |
| 10.02.2022 | Dyadic International : and Phibro Animal Health Announce Exc... | Dyadic and Phibro Animal Health Announce Exclusive License Agreement to Develop and Commercialize An... | marketscre... |
| 07.01.2022 | Dyadic International : Investor Presentation January 2022 | Revolutionary C1 Protein Production Platform Addressing Today'sVaccine & Therapeutic Shortfalls ... | marketscre... |
| 17.12.2021 | Dyadic Announces Research, License and Collaboration Agreeme... | JUPITER, Fla., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “... | marketscre... |
| 17.12.2021 | Dyadic International : Announces Research, License and Colla... | Dyadic Announces Research, License and Collaboration Agreement with Janssen for the Manufacture of T... | marketscre... |
| 11.11.2021 | Dyadic Reports Third Quarter 2021 Financial Results and High... | Dyadic Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress ● COVID-1... | marketscre... |
| 09.11.2021 | Dyadic Appoints Chief Business Officer to Executive Leadersh... | Dyadic Appoints Chief Business Officer to Executive Leadership Team JUPITER, FL / November 9, 2021 D... | marketscre... |
| 27.10.2021 | Dyadic to Report Third Quarter 2021 Financial Results on Wed... | JUPITER, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “... | marketscre... |
Show more